Molina Healthcare, Inc.
NYSE:MOHMedical - Healthcare Plans
-$4.68 today
- Market cap
- $10.78B
- Beta
- 0.80
- P/E (TTM)
- 53.0
- EPS (TTM)
- $3.69
Volume 1.33M
Average 1.37M
MOH Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Molina Healthcare, Inc.NYSE: MOH
Investing Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Investing cash flow turns negative
Q3 FY2026 investing cash flow was -$309M, compared with $77M a year earlier. Trailing-twelve-month investing cash flow was -$98M.
Context
- Investing cash flow amounted to 0.7% of revenue in FY2025, down 0.5 pp from a year earlier.
- Investing cash flow increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly investing cash flow holds near -$309M or moves back toward the trailing-twelve-month quarterly average of -$24.5M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 312M USD
- Year-over-year change
- +167.2%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 312M | +167.2% |
| FY2024 | 2024-12-31 | (464M) | +37.6% |
| FY2023 | 2023-12-31 | (744M) | +5.8% |
| FY2022 | 2022-12-31 | (790M) | +52.2% |
| FY2021 | 2021-12-31 | (1.65B) | — |
Investing Cash Flow vs competitors
How MOH compares with its peers on the latest reported figures
- MOH's LTM Sep 2026 investing cash flow of $98M is the 7th largest of the 8 companies compared; the peer median is $3.01B.
- Its year-over-year change of -197.0% is the 7th highest of 8, against a peer median of +56.7%.
- Investing cash flow amounts to 0.2% of revenue for MOH, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $11.43B | +58.9% | -32.7% | 2.5% | |
| LTM Sep 2026 | $4.26B | -370.2% | — | 2.8% | |
| LTM Jun 2026 | $3.32B | +249.2% | +2.1% | 21.7% | |
| LTM Sep 2026 | $3.01B | -12.8% | -33.5% | 1.5% | |
| LTM Sep 2026 | $2.83B | -32.2% | — | 1.0% | |
| LTM Jun 2026 | $1.62B | +174.7% | — | 0.8% | |
| LTM Sep 2026 | $98M | -197.0% | — | 0.2% | |
| LTM Mar 2026 | $10.93M | +56.7% | -19.0% | 0.3% | |
| Peer median (excluding MOH) | $3.01B | +56.7% | -25.9% | 1.5% | |
Competitors are the stored peer set for MOH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 659M | 792M | 1.09B | 1.18B | 472M |
| Depreciation & Amortization | 131M | 176M | 171M | 186M | 195M |
| Deferred Income Tax | (24M) | (66M) | (31M) | 53M | 43M |
| Stock-Based Compensation | 72M | 103M | 115M | 116M | 47M |
| Change in Working Capital | 1.22B | (448M) | 314M | (898M) | (1.29B) |
| Accounts Receivables | (415M) | (95M) | (778M) | (78M) | (145M) |
| Inventory | 0 | 0 | 778M | 0 | 0 |
| Accounts Payables | 138M | 55M | 328M | 115M | (221M) |
| Other Working Capital | 1.5B | (408M) | (14M) | (935M) | (923M) |
| Other Non-Cash Items | 58M | 216M | 2M | 8M | (3M) |
| Operating Cash Flow | 2.12B | 773M | 1.66B | 644M | (535M) |
| Capital Expenditures | (77M) | (91M) | (84M) | (100M) | (101M) |
| Acquisitions (Net) | (129M) | (134M) | (3M) | (344M) | (245M) |
| Purchases of Investments | (2.71B) | (1.91B) | (1.43B) | (1.13B) | (751M) |
| Sales of Investments | 1.33B | 1.4B | 772M | 1.11B | 1.41B |
| Other Investing Activities | (63M) | (50M) | 4M | 1M | 1M |
| Investing Cash Flow | (1.65B) | (790M) | (744M) | (464M) | 312M |
| Debt Repayment | 17M | 0 | 0 | 740M | 838M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (128M) | (400M) | (60M) | (1B) | (1B) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (19M) | (41M) | 2M | (87M) | (8M) |
| Financing Cash Flow | (183M) | (441M) | (58M) | (347M) | (170M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 283M | (458M) | 860M | (167M) | (393M) |
| Free Cash Flow | 2.04B | 682M | 1.58B | 544M | (636M) |
Molina Healthcare, Inc.
NYSE:MOH
Intrinsic Alpha fair value
Locked
Current Price
$206.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.